https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Enlicitide Offers a New Oral Option for Managing High Cholesterol

Enlicitide Offers a New Oral Option for Managing High Cholesterol

A new oral PCSK9 inhibitor, enlicitide, shows promise in significantly lowering LDL cholesterol, offering hope for hypercholesterolemia management and cardiovascular health.

administrator

Related Articles